PIK3CB and neoplasm: The sensitivity of the PI3K inhibitor pictilisib could be associated with lower activation of the mTORC1 complex, as mTORC1 activation has been described to be a crucial event in the resistance to PI3K inhibitors in many tumor types41,42.